✦ LIBER ✦

First-line thalidomide–dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

✍ Scribed by Abdelkefi, A; Torjman, L; Ben Romdhane, N; Ladeb, S; El Omri, H; Ben Othman, T; Elloumi, M; Bellaj, H; Lakhal, A; Jeddi, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line thalidomide–dexamethasone the

✍ Abdelkefi, A; Torjman, L; Ben Romdhane, N; Ladeb, S; Omri, H El; Ben Othman, T; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Thalidomide, dexamethasone and lovastati

✍ Marek Hus; Norbert Grzasko; Marta Szostek; Andrzej Pluta; Grzegorz Helbig; Dariu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Outcomes of autologous stem cell transpl

✍ Anagnostopoulos, A; Aleman, A; Yang, Y; Donato, M; Weber, D; Champlin, R; Smith, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

High-dose melphalan versus busulfan, cyc

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

High-dose chemotherapy with autologous s

✍ Colombat, Ph; Lemevel, A; Bertrand, P; Delwail, V; Rachieru, P; Brion, A; Bertho 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB